Abstract P1-09-09: Role of endocrine therapy in premenopausal patients with hormone receptor-positive metastatic breast cancer, compared with postmenopausal patients: Diachronic analyses from nationwide cohort in Korea (KCSG BR 14-07)

Autor: G.M. Kim, Y.S. Chae, K.H. Lee, J-H Ahn, Y-H Im, T-Y Kim, Jae Ho Jeong, Young-Ae Park, Se Lee, KS Lee, S-J Koh, KH Park, Ke Lee, J.H. Kim, S-A Im, EK Cho, JH Yoon, Jung Ho Sohn, HS Won, KH Jung

Publikováno v: Cancer Research. 76:P1-09

Background Endocrine therapy (E) has a major role in treatment of hormone receptor (HR)-positive metastatic breast cancer (MBC). However, in contrast to western countries, premenopausal patients (PRE) more prevalent (50% of all breast cancer patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::80a0d7f60ae44c4ebd41d10b1324f025
https://doi.org/10.1158/1538-7445.sabcs15-p1-09-09

Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron

Autor: Sy Kim, JC Lee, BY Ryoo, WK Kim, KH Lee, TY Kim, DS Heo, YH Park, Kyo-Young Lee, HY Lim, Yung-Jue Bang, EK Cho, KS Cho, YS Park, Ja Lee, HC Kim, NK Kim, DB Shin, YK Kang, HJ Yoon

Publikováno v: The Journal of international medical research. 30(3)

Control of nausea and vomiting is very important in determining patient compliance with cisplatin chemotherapy. A multicentre, randomized, single-blind study was conducted to compare the tolerability and efficacy of ramosetron with those of granisetr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b076d69f87cc3b748903e030294722b
https://pubmed.ncbi.nlm.nih.gov/12166338

Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.

Autor: Park C; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, Gumi-Ro, Bundang-Gu, Seongnam, 13620, Republic of Korea., Suh KJ; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, Gumi-Ro, Bundang-Gu, Seongnam, 13620, Republic of Korea., Kim SH; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, Gumi-Ro, Bundang-Gu, Seongnam, 13620, Republic of Korea. sehyunkim@snubh.org., Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, College of Medicine, Seoul, Republic of Korea., Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, College of Medicine, Seoul, Republic of Korea., Kim MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Jeong JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Lee KE; Department of Hematology and Oncology, Ewha Womans University Hospital, Seoul, Korea., Park YH; Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea., Kim HJ; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea., Cho EK; Division of Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Choi IS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea., Noh SJ; PentaMedix Co., Ltd, Seongnam, Korea., Shin I; PentaMedix Co., Ltd, Seongnam, Korea., Cho DY; PentaMedix Co., Ltd, Seongnam, Korea., Kim JH; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, Gumi-Ro, Bundang-Gu, Seongnam, 13620, Republic of Korea.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Aug 06; Vol. 73 (10), pp. 197. Date of Electronic Publication: 2024 Aug 06.

Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16).

Autor: Kim SH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea., Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, College of Medicine, Seoul, South Korea., Suh KJ; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea., Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, College of Medicine, Seoul, South Korea., Kim MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Park YH; Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, South Korea., Kim JY; Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, South Korea., Jeong JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Lee KE; Department of Hematology and Oncology, Ewha Womans University Hospital, Seoul, South Korea., Choi IS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, South Korea., Park KH; Division of Medical Oncology/Hematology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, South Korea., Kim HJ; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea., Cho EK; Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea., Park SY; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea., Kim M; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Kim JH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea. Electronic address: jhkimmd@snu.ac.kr.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113386. Date of Electronic Publication: 2023 Oct 14.

Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia.

Autor: Park YH; Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea., Kim DY; Department of Internal Medicine, Ewha Womans University Seoul Hospital, Ewha Womans University School of Medicine, Seoul, Korea., Mun YC; Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea., Cho EK; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Lee JH; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Jo DY; 4 Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea., Kim I; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Park SY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Kim B; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Bang SM; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Kim H; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea., Min YJ; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea., Park JH; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea., Seo JJ; Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea., Moon HN; Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea., Lee MH; Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Korea., Kim CS; Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Korea., Lee WS; Department of Hemato/Oncology, Inje University Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea., Chong SY; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea., Oh D; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea., Zang DY; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea., Lee KH; Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea., Hyun MS; Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea., Kim HS; Department of Pediatrics, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea., Kim SH; Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea., Kwon H; Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea., Kim HJ; Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea., Park KT; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea., Bae SH; Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, Daegu, Korea., Ryoo HM; Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, Daegu, Korea., Choi JH; Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea., Ahn MJ; Department of Internal Medicine, Hanyang University Medical Center, Hanyang University College of Medicine, Seoul, Korea., Yoon HJ; Department of Internal Medicine, Kyung Hee University Hospital, College of Medicine, Kyung Hee University, Seoul, Korea., Nam SH; Department of Internal Medicine, Seoul Veterans Hospital, Seoul, Korea., Kim BS; Department of Internal Medicine, Seoul Veterans Hospital, Seoul, Korea., Seong CM; Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.

Publikováno v: The Korean journal of internal medicine [Korean J Intern Med] 2022 Jul; Vol. 37 (4), pp. 841-850. Date of Electronic Publication: 2022 Jun 28.